These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2835113)

  • 21. D1 and D2 dopamine receptors differentially increase Fos-like immunoreactivity in accumbal projections to the ventral pallidum and midbrain.
    Robertson GS; Jian M
    Neuroscience; 1995 Feb; 64(4):1019-34. PubMed ID: 7753373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic BRL 43694, a selective 5-HT3 receptor antagonist, fails to alter the number of spontaneously active midbrain dopamine neurons.
    Ashby CR; Jiang LH; Wang RY
    Eur J Pharmacol; 1990 Jan; 175(3):347-50. PubMed ID: 2157603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The electrophysiological actions of dopamine and dopaminergic drugs on neurons of the substantia nigra pars compacta and ventral tegmental area.
    Mercuri NB; Calabresi P; Bernardi G
    Life Sci; 1992; 51(10):711-8. PubMed ID: 1355254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Firing patterns of midbrain dopamine neurons: differences between A9 and A10 cells.
    Grenhoff J; Ugedo L; Svensson TH
    Acta Physiol Scand; 1988 Sep; 134(1):127-32. PubMed ID: 3239415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for a functional role of dopamine type-1 (D-1) receptors in the substantia nigra of rats.
    Matthews RT; German DC
    Eur J Pharmacol; 1986 Jan; 120(1):87-93. PubMed ID: 2868905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurobehavioral evidence for mesolimbic specificity of action by clozapine: studies using electrical intracranial self-stimulation.
    Gardner EL; Seeger TF
    Biol Psychiatry; 1983 Dec; 18(12):1357-62. PubMed ID: 6661466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the action of the stereoisomers of the psychostimulant 4-methylaminorex (4-MAX) on midbrain dopamine cells in the rat: an extracellular single unit study.
    Ashby CR; Pan H; Minabe Y; Toor A; Fishkin L; Wang RY
    Synapse; 1995 Aug; 20(4):351-61. PubMed ID: 7482294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system.
    Andersson JL; Nomikos GG; Marcus M; Hertel P; Mathé JM; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Oct; 352(4):374-85. PubMed ID: 8532065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition.
    Ugedo L; Grenhoff J; Svensson TH
    Psychopharmacology (Berl); 1989; 98(1):45-50. PubMed ID: 2524859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Responses of intracellularly recorded cortical neurons to the iontophoretic application of dopamine.
    Bernardi G; Cherubini E; Marciani MG; Mercuri N; Stanzione P
    Brain Res; 1982 Aug; 245(2):267-74. PubMed ID: 6289964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amphetamine-induced increase in motor activity is correlated with higher firing rates of non-dopamine neurons in substantia nigra and ventral tegmental area.
    Olds ME
    Neuroscience; 1988 Feb; 24(2):477-90. PubMed ID: 3362350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute and chronic administration of the selective 5-HT1A receptor antagonist WAY-405 significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Minabe Y; Schechter L; Hashimoto K; Shirayama Y; Ashby CR
    Synapse; 2003 Dec; 50(3):181-90. PubMed ID: 14515335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The orexin-1 receptor antagonist SB-334867 blocks the effects of antipsychotics on the activity of A9 and A10 dopamine neurons: implications for antipsychotic therapy.
    Rasmussen K; Hsu MA; Yang Y
    Neuropsychopharmacology; 2007 Apr; 32(4):786-92. PubMed ID: 17063151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clozapine, haloperidol, and the D4 antagonist PNU-101387G: in vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin release.
    Broderick PA; Piercey MF
    J Neural Transm (Vienna); 1998; 105(6-7):749-67. PubMed ID: 9826116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of injecting 6-hydroxydopamine into areas of the nigro-striatal (A9) and mesolimbic (A10) dopaminergic systems on the elaboration of a conditioned feeding reflex in the rat].
    Zhukova EM; Spiridonov VK; Loskutova LV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1987; 37(1):88-94. PubMed ID: 3107237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of thyrotropin releasing hormone on rats with lesions of the mesolimbic and nigrostriatal dopamine systems.
    Andrews JS; Sahgal A
    Physiol Behav; 1985 Jul; 35(1):93-7. PubMed ID: 2997819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between the discharge rate of non-dopamine neurons in substantia nigra and ventral tegmental area and the motor activity induced by apomorphine.
    Olds ME
    Neuroscience; 1988 Feb; 24(2):465-76. PubMed ID: 3362349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nicotinic effects on the firing pattern of midbrain dopamine neurons.
    Grenhoff J; Aston-Jones G; Svensson TH
    Acta Physiol Scand; 1986 Nov; 128(3):351-8. PubMed ID: 3788613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitization to repeated enkephalin administration into the ventral tegmental area of the rat. II. Involvement of the mesolimbic dopamine system.
    Kalivas PW
    J Pharmacol Exp Ther; 1985 Nov; 235(2):544-50. PubMed ID: 4057084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of the A10 mesolimbic system by the sigma-receptor agonist (+)SKF 10,047 can be blocked by rimcazole, a novel putative antipsychotic.
    Ceci A; Smith M; French ED
    Eur J Pharmacol; 1988 Sep; 154(1):53-7. PubMed ID: 2903063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.